UFPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

UFP TECHNOLOGIES INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$293.25+1.58 (+0.54%)

Close on Oct 19, 2026

Market cap: $2.28B
P/E (TTM): 31.6
Dividend yield: –

UFP TECHNOLOGIES INC income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Revenue	603	504	400	354	206	179	198	190	148	146	139	139	139	131	127	121	99
Cost of Revenue	432	358	288	264	155	135	144	142	112	111	101	102	98	93	91	86	73
Gross Profit	170	147	112	90	51	45	54	48	35	35	37	37	41	38	36	35	27
Research & Development	8.60	10	7.20	9.30	8.50	8.20	8.80	11	5.00	1.30	1.30	1.40	1.20	1.30	1.20	0.90	–
Selling, General & Admin	77	62	51	46	29	27	29	28	24	24	24	24	24	22	21	20	19
Operating Income	92	81	58	55	21	17	25	20	12	12	12	12	17	17	16	14	8.19
Interest Expense	9.80	8.06	3.65	2.76	0.04	0.08	0.67	1.32	0.05	0.07	0.09	0.15	–	–	–	–	–
Interest & Investment Income	–	–	–	–	0.05	0	0	0.05	0.22	0.15	0.11	0.05	–	–	–	–	–
Income from Equity Investments	0.12	0.09	0	0	–	–	–	–	–	–	–	–	–	–	–	–	–
Other Non-Operating Income	-0.02	0.19	-0.12	0.08	0.03	-0.37	-0.39	0.06	0.17	0.08	0.03	0.20	-0.21	-0.09	-0.03	0.03	0.61
Merger & Restructuring Charges	–	–	–	–	–	–	–	–	0.06	0.42	1.76	1.56	–	–	–	–	–
Gain (Loss) on Sale of Assets	-0.04	-0.11	-0.15	6.15	0.01	-0.46	0	0.05	-0.01	0.00	-0.03	-0.01	-0.01	0.01	0.84	0.01	0.01
Legal Settlements	–	–	–	–	–	–	–	0.10	0.12	2.11	–	–	–	–	–	–	–
Pretax Income	83	73	54	53	21	16	24	18	12	12	12	12	17	17	16	14	8.80
Income Tax Expense	14	14	8.98	11	5.32	2.91	3.90	4.09	2.65	4.35	4.15	4.21	5.92	5.68	4.91	5.02	2.82
Net Income incl. Noncontrolling Interests	–	–	–	–	–	–	–	–	–	–	–	7.56	11	11	11	9.41	5.98
Minority Interest in Earnings	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.44	0.16	0.05
Net Income	68	59	45	42	16	13	20	14	9.21	7.97	7.59	7.56	11	–	–	–	–
Net Income to Common	–	–	–	–	–	–	–	–	–	–	–	–	11	11	10	9.25	5.93
EPS (Basic)(per share)	8.87	7.69	5.89	5.52	2.11	1.79	2.66	1.95	1.27	1.11	1.07	1.08	1.65	1.63	1.60	1.50	1.02
EPS (Diluted)(per share)	8.75	7.58	5.83	5.45	2.09	1.77	2.63	1.93	1.26	1.10	1.05	1.05	1.59	1.55	1.48	1.37	0.94
Shares Outstanding (Basic, Weighted)(shares)	7.71	7.67	7.62	7.56	7.52	7.48	7.42	7.35	7.25	7.19	7.10	7.03	6.82	6.68	6.48	6.16	5.83
Shares Outstanding (Diluted, Weighted)(shares)	7.80	7.79	7.70	7.66	7.62	7.57	7.52	7.43	7.34	7.28	7.21	7.18	7.11	7.03	7.00	6.75	6.29
EBITDA	111	96	69	67	30	25	33	27	17	18	17	16	21	20	18	18	11
Net Interest Income	–	–	–	–	–	–	–	–	–	–	0.03	-0.11	-0.21	-0.09	-0.03	-0.12	-0.23

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 28.5%
Operating margin: 15.3%
Net margin: 11.4%
Return on equity, FY2025: 17.8%

Financial strength

Current ratio: 3.00
Debt to equity: 0.25
Debt to assets: 17.2%
Cash to current liabilities: 11.6%

Valuation

P/E ratio: 31.6
Price to sales: 3.62
Price to book: 4.94
Dividend yield: –